Introduction of the Non–Small Cell Lung Cancer Face-Off

July 31, 2024

By Joshua K. Sabari, MD
Roy S. Herbst, MD, PhD

Opinion

Video

Joshua K. Sabari, MD, introduces a Face-Off program in which Northwestern University and the University of Chicago will present data and discuss treatment practices in non–small cell lung cancer.

Now Viewing

EP: 1.Introduction of the Non–Small Cell Lung Cancer Face-Off

EP: 2.BRIGHTSTAR: Local Consolidative Therapy with Brigatinib in TKI-naïve ALK-rearranged Metastatic NSCLC

EP: 3.Lorlatinib vs Crizotinib in Patients With Advanced ALK-Positive NSCLC: 5-Year Outcomes from the Phase III CROWN Study

EP: 4.Osimertinib for EGFRm Stage III Unresectable NSCLC: The LAURA Trial

EP: 5.Amivantamab plus Lazertinib in Atypical EGFR-mutated Advanced NSCLC: Results from CHRYSALIS-2

EP: 6.Patient Case: A 76-Year-Old Woman with ROS1+ Metastatic NSCLC

EP: 7.Patient Profile: A 57-Year-Old Woman with NSCLC

EP: 8.Clinical Scenario: A PD-L1-Low Patient with NSCLC

EP: 9.Patient Case: KRAS G12C Non–Small Cell Lung Cancer

EP: 10.Will Neo-Adjuvant Therapies Replace Surgery plus Adjuvant Treatment for Resectable NSCLC?

EP: 11.Treatment Options for Patients with EGFRm NSCLC

EP: 12.Face-Off: Award Presentation Ceremony

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!